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Abstract: (200 words) 
Multidetector computed tomography (MDCT) has been the benchmark for visualizing bony changes of the ear but 
has recently been challenged by cone-beam computed tomography (CBCT).  In both methods with 2D or 3D 
imaging all inner ear bony structures can be visualized satisfactorily. Both of these imaging methods produce 
ionizing radiation and induce adverse health effects, especially among children. In 3T magnetic resonance imaging 
(MRI) the soft tissue can be highly accurately imaged. Use of gadolinium chelate (GdC) as a contrast agent allows 
the partition of fluid spaces to be visualized, such as the bulging of basilar and Reissner’s membranes.. Both 
intravenous and intratympanic administration of GdC has been used. The development of the positive endolymph 
imaging method, which visualizes endolymph as a bright signal and the use of image subtraction seems to allow 
more easily interpretable images. This long-awaited possibility of diagnosing endolymphatic hydrops in living 
human subjects has enabled the definition of Hydropic Ear Disease, encompassing typical Meniere’s disease as 
well as its monosymptomatic variants and secondary conditions of endolymphatic hydrops. The next challenge in 
imaging of the temporal bone is to perform imaging at the cellular and molecular level. This chapter provides an 
overview of current temporal bone imaging methods and a review of emerging concepts in temporal bone imaging 
technology.   
 
  
4 
 
Introduction.  
Rapid development of radiological equipment over the last several decades has significantly promoted the role of 
imaging in otology. Computed tomography (CT) and magnetic resonance imaging (MRI) have become an integral 
part of the evaluation of children and adults with hearing loss and diseases associated with temporal bone. The 
currently used Multi Detector CT (MDCT) techniques allow bony tissue determination with an accuracy of 0.1 
mm. Recently cone-beam computed tomography (CBCT) technology has become particularly attractive for 
temporal bone imaging as CBCT imaging reduces the exposure to ionizing radiation when compared with 
traditional MDCT. However, changes in inner ear fluid spaces became possible only with 3T or higher MRI 
equipment in combination with contrast agents and special imaging techniques.  
Abnormalities on CT or MRI are found in 20% to 50% of children with sensorineural hearing loss and correlate 
with the degree of hearing loss(1). Imaging of the temporal bone by using both MRI and MDCT is likely the future 
gold standard for temporal bone imaging (2). Some recent and novel imaging methods used experimentally in 
temporal bones have not yet been applied clinically such as optical coherence tomography imaging (3) (4) (5), 
microtomography (µCT) (6) and endoscopes using coherent anti-Stokes Raman spectroscopy (CARS) technique (7)   
these (7), development of advanced of contrasting agents  (8) and these may provide additional imaging benefits in 
the future. This chapter provides an overview of current temporal bone imaging methods and a review of emerging 
concepts in temporal bone imaging technology.   
CT 
CT is the most common modality for assessing the bony anatomy of the temporal bone. CT can detect signs of 
perilymphatic fistulae (i.e. pneumolabyrinth) but fails to detect subtle traumatic lesions within the inner ear, such as 
labyrinthine haemorrhage or axonal damage along central auditory pathways (9). Many anatomic structures of the 
middle and inner ears are not optimally depicted using conventional CT with image reconstruction in the standard 
axial and coronal planes. In early development of CT, cochlear partitioning and soft tissue membranes were not 
adequately visualized (10) (11). Recent advances in MDCT, including the development of scanners with 32 
detector rows (64 effective sections) for depiction of normal anatomy and pathologic states in the temporal bone, 
allow the acquisition of isotropic voxels that can be reconstructed and used in the multiplanar reconstructions of 
volumetric CT images (12). This technique gives radiologists the opportunity to visualize the anatomic structures of 
the middle and inner ears accurately (table 1) (13). Recent reconstruction methods in MDCT may also allow  
5 
 
Legend for table 1: Synopsis of the anatomically important structures and the respective primary criteria for image 
quality assessment. Rated as: -= not visible, += poorly, ++= moderately and +++= good visible. (6) (54)  
 
visualization of the cochlear partitioning (9). A recent paper by Maillot et al. (12) indicated that MDCT allows 
radiologists to examine the complex anatomy of the temporal bone with sub-millimeter resolution and is the first 
Structure/Condition                          Review Criteria MDCT CBCT MRI 
Cochlea                                                       Normal contour, 2.5 turns +++ +++ +++ 
Intracochlear calcification Ability  to discern intracochlear ossifications ++ +++ +\- 
Osseous spiral lamina                                 Presence, integrity  - - - 
Modiolus                                        Presence, integrity  ++ ++ + 
   Vestibule                                         Contour, density  +++ +++ + 
Semicircular canals Contour, density, Hypo-/Aplasia, dehiscence +++ +++ ++ 
Vestibular aqueduct                                     Contour, density  +++ +++ + 
Cochlear aqueduct                                Contour, density  ++ +++ +++ 
Cochlear nerve                                   Presence + + +++ 
Bony lamella  at auditory 
canal fundus 
Presence, integrity  of bony lamella separating the internal 
auditory canal from the cochlea 
+ + +++? 
Internal auditory canal                                Contour +++ +++ +++? 
Facial nerve canal, 
cochlear segment  
Contour, course ++ +++ - 
Facial nerve canal, 
tympanic segment 
Contour, course +++ +++ - 
Facial nerve canal, 
mastoid segment 
Contour, course  +++ +++ - 
Middle ear cavity                                       Aeration +++ +++ +++ 
Malleus                                           Presence of all parts  ++ +++ - 
Incus                                                              Presence of all parts  ++ +++ - 
Stapes                                               Presence of all parts  ++ +++ - 
Round window                                  Presence, aperture  ++ +++ - 
Round window niche                            Borders, aeration ++ +++ - 
Oval window                                    Presence, borders, footplate  position  ++ +++ - 
Internal carotid artery 
canal                       
Borders, osseous wall dehiscence  +++ +++ - 
Jugular foramen / jugular 
bulb                                          
Borders, osseous wall  dehiscence  +++ +++ - 
Mastoid                                           Bony borders, aeration +++ +++ - 
Perilymphatic space Gadolinium contrasted,  - - +++ 
Endolymphatic space Not contrasted - - +++ 
Stria vascualris If leaking and contrasted - - +++ 
Cochleo-vestibular nerve Tissue growth > 1 mm - - +++ 
Canal for subarcuate 
artery 
Course and contour visualized by CT and MRI  +++ ? +++ 
Singular canal Course and contour visualized by CT and MRI  +++ ? +++ 
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modality of choice. Indeed, it is capable of revealing a broad spectrum of ossicular lesions that may not be apparent 
on the basis of clinical findings alone. 
For MDCT the slice thickness is a critical point and detailed anatomical evaluation as small as 0.2 mm slice 
intervals have been used (12). The MDCT technique may help to overcome the limitations long imposed by 
restrictions in gantry angle and patient positioning and improves diagnostic accuracy. The main advantages of 
MDCT for temporal bone imaging are shorter acquisition times, a decrease in tube current load and better spatial 
resolution. The short acquisition time is an advantage especially when dealing with younger patients, or those with 
claustrophobia or severe pain that often need sedatives for appropriate image acquisition. The ability of MDCT to 
obtain images of temporal bones bilaterally in one scan is another reason why MDCT is effective for imaging the 
temporal bone. Additional techniques such as virtual otoscopy with 3-D reconstructions of MDCT images can 
provide a different view on ossicular chain anomalies in traumatic conditions (14). CT has been considered the 
gold-standard method for postoperative imaging of the electrode position after cochlear implantation (CI),although 
plain X-ray films have been used (15, 16).  
In detecting a thin bony coverage of a superior semicircular canal, digital volume tomography (DVT) scans seem to 
be superior to MDCT scans (13). Giesemann and Hofmann (9) indicated that CT is the gold standard in imaging 
diagnosis of semicircular canal dehiscence syndrome (SCDS).; however, it has a high false-positive rate and may 
be misleading in terms of diagnosis because it overestimates the size of the dehiscence and the prevalence (17).  In 
addition, many patients with imaging findings of superior canal dehiscence do not suffer from a clinical dehiscence 
syndrome.  In those with SCDS there is no clear linear relationship between the size of the dehiscence and the 
extent of clinical symptomatology, however the dehiscence length does correlate positively with the maximal air-
bone gap (17). Nevertheless, a definite diagnosis of SCDS is difficult with any radiologic imaging technique (18). 
It has been reported that subarcuate venous malformations cause audio-vestibular symptoms similar to those of 
SCDS and should be excluded in temporal bone imaging (19). 
The National Cancer Institute of United States estimates that approximately 5 to 9 million CT examinations are 
performed annually on children all over the country (20). Despite the many benefits of CT, a disadvantage is the 
inevitable radiation exposure. Although CT scans comprise approximately12 per cent of diagnostic radiological 
procedures in large U.S. hospitals, it is estimated that they account for approximately 49 per cent of the U.S. 
population's collective radiation dose from all medical x-ray examinations (20). An association between increased 
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risk of cancer and CT scans has been reported especially in children (21), (22) (23). The National Cancer Institute 
of United States estimates that a radiation dose of 50 mSieverts (mSv) increases of the risk of cancer by threefold, 
particularly in children  (20, 22, 24). This dose reflects CT imaging performed in 5-10 head CT scans. The lifetime 
cancer mortality risk is estimated to be approximately 14% per Sv for a 1-year-old child, 5% per Sv for a middle-
aged adult, and based on current models less than 2% per Sv for an individual older than 60 years (23).  
To avoid high radiation dose the novel “low dose protocols” of MDCT have been developed and a compromise 
between dose and resolution has been made (25) (26). The tube current-time product and voltage can be reduced by 
50% without increasing artefacts. (26)  Low-dose postoperative MDCT scans are sufficient for localizing the CI 
electrode (26) and reduce metal artefacts (25). The application of conventional CT in otolaryngology might be 
replaced by cone-beam computed tomography (CBCT) in the future (27, 28).  For congenital malformations of the 
inner ear MDCT has a long history and is an outstanding tool to visualize anatomical changes. Ultra-high resolution 
CT (UHR-CT) with collimation of 0.25mm is coming to clinical field soon (29). Future study is warranted to 
compare the ability of CBCT and UHR-CT, although CBCT might have the advantage in terms of radiation dose 
reduction.  
CBCT 
In CBCT, a pulsed cone shaped X-ray beam performs a single rotation around a patient simultaneously acquiring 
all of the necessary volumetric data for the reconstruction of separate images in the sagittal, coronal, and axial 
planes. In the temporal bone any interface between two materials (as from fluid to the bone), is a step in tissue 
anatomy, but like a ramp in the CBCT image. The width of the ramp depends on factors such as detector pixel size, 
image acquisition geometry and radiation source focal spot size. This process differs from traditional MDCT that 
reconstructs images using a series of axial slices. CBCT creates less streak artefacts and offers higher spatial 
resolution than MDCT (cubic voxel size of approximately 0.07 mm versus 0.1 –0.6 mm, respectively). Erovic et al. 
(27) promoted the use of CBCT in intraoperative monitoring of the temporal bone. CBCT has a smaller footprint 
compared with MDCT, which makes it more feasible for use in outpatient departments or operating theatres. CBCT 
is reportedly capable of demonstrating fine structures of the middle and inner ears as well as pathological diseases 
within temporal bone, such as otosclerosis (30). In the assessment of SCDS, CBCT is suggested to be more reliable 
than MDCT (31). 
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CBCT appears to provide sufficient spatial accuracy for intraoperative usage during temporal bone surgery (32) 
(27). Identifying the location of implants is becoming increasingly important in modern otology, which involves 
applications such as the Vibrant Soundbridge implant and CI (6, 33) (34). With regard to monitoring the electrode 
array location during CI surgery, there is an emerging need to improve the imaging quality to better assess 
electrode trauma to the fine structures of the cochlea, such techniques include low-dose iterative reconstruction, 
scatter correction, lag correction, and metal artifact reduction (35) (36) (37) (38). Gupta et al. (39) refined the 
technology for temporal bone imaging using a smaller detector element and acquired a total of 900 cone-beam 
projections under a field of view of 15.5 cm; however, the image quality was not perfect. Furthermore, metal 
electrodes tend to cause artifacts that may blur the images (40). In assessment of the location of the cochlear 
implant with CBCT Pearl et al (41) could not clearly detect the basilar membrane to designate exact scalar location, 
which is consistent with previous reports. Zou et al (6) used the osseous spiral lamina of cochlea to assess the 
location of cochlear implant and to delineate between the scalae (Fig. 1). The scalar position, has also been 
evaluated by Ruivo et al. (42) and Verbist et al. (43), and in their study the osseous spiral lamina was visible in all 
sections.  
Figure 1. A cochlear implant electrode located in the cochlea imaged with CBCT. Osseous spiral lamina is visible 
in all turns and the locations of electrodes are typically leaning on the lateral wall in the scata tympani. With 
permission of Acta Otolaryngol (Stokh.) (32). 
 
 
 
Ruivo et al (42) concluded that CBCT provides high-resolution and almost artefact-free multiplanar reconstruction 
images allowing assessment of the precise intracochlear position of the electrode and visualization of each of the 
individual contacts; the CBCT visualization consisted of 23 middle and inner ear structures using a 5-point scale. 
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They showed that insufficient image-quality scores were more frequent in low-dose scans versus high-dose scans, 
however, the difference was only statistically significant for otologists but not for neuroradiologists. Image quality 
was critical for small structures (such as the stapes or lamella at the internal auditory canal fundus). The CBCT 
images can discern individual electrode contacts, often not possible on MDCT (44) (45). In addition, Pearl et al 
(41) demonstrated that CBCT improved imaging of the cochlea and facial nerve canal, enabling identification of 
electrode contacts in close proximity to the fallopian canal and therefore most prone to induce inadvertent 
stimulation of the facial nerve.  
Zou et al (42) (28) evaluated the effects of filters, voltage and frame numbers in visualization of the inner ear using 
CBCT among isolated human temporal bones; each temporal bone was independently analysed by two imaging 
engineers and 3 otologists; each investigator had at least 15 years of experience with temporal bone CT and were 
blinded to the dose-relevant scan parameters during the review of the scan. In 2D imaging in all temporal bones the 
land marks of modiolus, osseous spiral lamina, and bony wall of cochlear duct that isolate scala vestibuli from scala 
tympani were demonstrated at a level in that the anatomic structures were fully assessable in all parts and 
acceptable image quality (table 1). Basilar membrane was not visualized in the cochlea. Changes in the tube current 
from 8 mA to 12.5 mA resulted in a minimal change of the temporal bone image quality. The tube voltage of 80 kV 
provided best images using 900 frames. In 3D images contrasts adjustment allowed very high quality of imaging of 
inner ear (fig. 2). The low X-ray dose is mostly a result of the small region scanned and the low kV used in CBCT 
(79 kV). The reason why the artefacts in the work of Zou et al. (6) were relatively minor in comparison of a 
previous work is that a suitable adjustment on the “γ curve” of the original images that suppresses the metal 
artefacts on the images was employed, and in addition improved imaging sharpness was achieved by using a pause 
during each exposure (e.g., start-stop-expose-start-stop-expose) together with high frames of two dimensional 
images, which was not previously reported (38).  
Figure 2. CBCT imaging using 900 frame numbers and 1.72 magnification factor on a temporal bone. A sharp 
image of the stapes was demonstrated in the temporal bone. Abbreviations: AC: anterior crus; FP: footplate; PC: 
posterior crus. ISJ: incudo-stapedial joint; LPI: lenticular process of incus. The black scale bar in the right lower 
corner = 2.5 mm. With permission of Annals of Otology, Rhinology & Laryngology (49). 
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With CBCT the full course of the subarcuate canal from the subarcuate fossa to the mastoid antrum can be 
accurately visualized, and the accompanying air cells were distinguished from the subarcuate canal in a temporal 
bone with a pneumatized superior semicircular canal wall (46) (47). The novel high-resolution CBCT system 
potentially has the power to detect changes associated with SCCD. 
A comparison of low-dose MDCT and CBCT image quality after cochlear implantation revealed that the visibility 
of cochlear inner and outer walls and overall image quality were positively correlated with radiation dose on 
MDCT; image quality was better with clinical MDCT than with CBCT protocols (48). In other comparisons, 
differences between systems were found, but a distinction between CBCT and MDCT could not be made (48). The 
effective radiation dose of the CBCT protocols was 6 to 16% of the clinical MDCT dose. 
Yamane et al. (49) evaluated the diagnostic properties of 3D CBCT images among 25 patients with Meniere’s 
disease (MD) and 13 healthy patients. They developed algorithms to determine the optimal 3D-CBCT window 
settings for the detection of water, muscle, calcium carbonate, and bone (48).  It was suggested that 3D CBCT 
imaging changes in the membranous labyrinth may be useful for the objective diagnosis of MD, that dislodged 
saccular otoconia may have an important role in MD, and that CBCT may be useful even in inner ear membrane 
imaging (48). 
In CBCT the total radiation dose of the work in Zou et al (46) was 13 µSv in male phantom head... The most 
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dominant contributor to the effective dose was bone marrow (36%-37%) followed by brain (34%-36%), remainder 
tissues (12%), extra-thoracic airways (7%), and oral mucosa (5%) (46). It is important to note that in this study the 
dose was measured with an anthropomorphic model with controlled error marginal. These results were in 
accordance with results of a previous study that demonstrated effective doses between 35.2 – 137.6 µSv (50). In 
some reports there is estimation of even lower dose of radiation in CBCT imaging (30) but  the estimated values 
may significantly deviate from the measured values (51). In a comparable study Erovic et al. (27) reported that the 
radiation dose of CBCT per scan is ~10 mGy (~0.35 mSv) to a dosimetry head phantom at 100 kVp and 170 mA, 
and was low compared with a typical 2 to 5 mSv diagnostic head CT and as high as 4.8 mSv have been reported 
(42) (52).  
MRI 
High resolution MRI imaging has an advantage over all types of CT imaging of the temporal bone as it provides 
better characterization of soft tissue and fluid-filled partitions. Despite several advantages, the major limitations of 
this method are the lack of bony details. Even with the recently developed ultra-short echo time pulse sequence, 
middle ear ossicles are only partly visualized (53{Naganawa, 2016 #1182). This is due to the lack of water 
containing material in the dense cortical bones. Another major disadvantage of using this method in temporal bone 
imaging is the high cost of the examination and the sedation needed for younger patients or patients in severe pain. 
In addition, this method cannot be used for implant imaging or intra-operative imaging where metal objects are 
involved in the operations as the superconducting magnets will attract the metals and electronic devices. For 
patients who are allergic to certain contrast agents, another type of contrast agent that may be more costly is 
required.  
MRI is the modality of choice when investigating the inner ear and suspecting soft tissue growth such as vestibular 
schwannoma, vascular malformations, endolymphatic hydrops or pathology of the cochlear aqueduct (54). 
Naganawa et al. (55) (56)  (57) developed specific algorithms using Fluid Attenuation Inversion Recovery 
sequences (FLAIR) that will demonstrate minute amounts of contrast agent in the inner ear (56) (58). The use of 
MRI in temporal bone imaging is dependent on the area to be visualized, the patient’s age, the pathology involved 
and its severity level. MRI is the gold standard in radiologic evaluation of soft tissue changes in the temporal bone 
and may serve as a complementary method when CT is used to characterize the bony structures.  
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MRI diagnosis of MD has been challenging until recent years (59)  The first efforts to demonstrate visualization of 
fluid spaces in the inner ear with GdC were carried out in animal studies by using animal MRI equipment of 4.7 T 
scanner (60). After demonstrating the contrasting of perilymph, Zou et all (61) (62) were the first to demonstrate 
that in the guinea pig endolymphatic hydrops could be visualized accurately and that the changes respected the 
histological verification of the degree of endolymphatic hydrops. These findings were followed  by Niyazov et al. 
(63) who showed similar results using a clinical 1.5 T machine.  In humans using 1.5T MRI, the passage of GdC 
delivered transtympanically, was shown to accumulate in the inner ear after 12 h post injection and fully contrasted 
the labyrinth after 24 h post injection. However 1.5T MRI equipment was not sensitive enough to demonstrate the 
delicate details of the perilymph and endolymph borders (64).   Figure 3 demonstrates the cochlear fluid spaces and 
endolymphatic hydrops (59).   
 
The recent development of 3T MRI provides a tool for visualizing endolymphatic hydrops with GdC as the contrast 
agent (65) (66) (67) (fig. 3). MRI especially in Japan ,Germany and just recently in USA has become a clinically 
useful tool for the diagnosis of atypical cases as well as typical cases of MD. Methodological development in 
imaging techniques and increase of the magnetic field strength have allowed separation of bone from fluid and 
contrast agent, and have improved spectral resolution, signal-to-noise ratio and contrast intensity and reduced scan 
acquisition times (55) (56) (68).  These properties are particularly helpful in the attempt to resolve details between 
the minute fluid filled spaces within the inner ear (approximately50 µl for endolymph and 150 µl for perilymph!).   
 
Figure 3. Endolymph and perilymph in the inner ear. (A) normal, (B) endolymphatic hydrops. The endolymph 
(gray) is surrounded by the perilymph (black) except for endolymphatic duct (ED) and endolymphatic sac (ES). U: 
utricle, S: saccule, St: stapes, R: round window. With permission of Auris Nasus Larynx (70)   
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A grading scale for the degree of endolymphatic hydrops has been proposed for use in research settings that was 
validated using identical histologic criteria and has also been applied also to clinical evaluations (61) (69) (70). The 
normal limit of ratio of the endolymphatic area over the vestibular fluid space (sum of the endolymphatic and 
perilymphatic area) is 33 % and any increase in the ratio would be indicative of EH (70) (71). According to the 
criteria, mild endolymphatic hydrops in the vestibule covers the ratio of 34% to 50% and significant endolymphatic 
hydrops covers the ratio of more than 50% in the vestibule (70). The respective evaluation of the ratio of the 
endolymphatic area over the total fluid space in the cochlea is correlated to displacement of Reissner’s membrane. 
Normally the Reissner’s membrane remains in situ and is shown as a straight border between the endolymph 
containing scala media and the perilymph containing scala vestibuli. Mild endolymphatic hydrops displays an 
extrusion of the Reissner’s membrane towards the scala vestibuli and results in an enlargement of the scala media 
with an area of less than that of the scala vestibuli. Severe endolymphatic hydrops causes an increase of the scala 
media with an area larger than that of the scala vestibule (70). A similar grading system on the ordinal level, with 
three degrees of severity for cochlear hydrops (mild, marked, extreme), has also been proposed (72). In cadavers 
without symptom history, the ratio of the endolymphatic space to the total vestibular fluid space ranged from 26.5 
% to 39.4 % (70) (73)   
The perilymphatic space facing the vestibule is sealed by the annular stapedial ligament and the perilymphatic 
space of scala tympani is sealed by the round window membrane. Animal and human experiments indicated that on 
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MRI the perilymphatic space in the vestibule is filled with GdC earlier and more intensively than the perilymphatic 
space of scala tympani (74) (75). Thus the cochlear perilymph space was often poorer filled with GdC than the 
vestibular part.  Zou et al. performed a series of experiments by sealing either the round or oval windows and 
demonstrated that the permeability of the round window was poorer than that of the oval window (76) (77) (78). 
This explains also why treatment of severe Meniere’s disease with low dose gentamicin infrequently causes 
deafness (less than 5% with two gentamicin injections) (79, 80) but is effective in ablation of vestibular complaints. 
For the visualization of inner ear membranes therefore it is important to fill the upper posterior part of the middle 
ear cavity with GdC so that the contrast agent has the possibility to be transported also via the oval window as the 
annular ligament is quite porous. Intratympanic administration of GdC provided efficient loading of the contrast 
agent in the inner ear perilymph and reduced the risk of systemic toxicity but raised concerns of local toxicity, as it 
is off label and requires puncture of the tympanic membrane. Such local toxicity was not observed during short, 
medium or long-term follow-up (81) (82) (83). In addition, image quality might be compromised owing to impaired 
GdC penetration of the round and oval window membranes  (78) (84)  and only the injected side of the inner ear 
can be evaluated (58). To evaluate both ears simultaneously, it is necessary to inject GdC into both sides (85) (68) 
(86). These drawbacks hinder the widespread use of this procedure (87). The development of more sensitive MRI 
techniques facilitates endolymphatic hydrops imaging using a single dose of intravenous GdC (56, 88) ; this method 
has become intensively used as clinical research method (89) (90) (91). To establish the normal range of 
endolymph ratio, healthy volunteers were scanned after intratympanic (70) (73) and intravenous (92) GdC 
applications. Figure 4 demonstrates visualization of endolymphatic hydrops with different MRI protocols. 
 
Figure 4. Fig. 1 a 72-year-old man with the clinical suspection of left Meniere’s disease. Images are obtained 4 
hours after IV-SD-GBCM. Conceptual diagram for the image generation of HYDROPS-Mi2 and HYDROPS2-Mi2. 
Upper row images indicate the generation of HYDROPS-Mi2. HYDROPS image, which is the subtraction of 
positive endolymphatic image (not shown) from positive perilymphatic image (heavily T2-weighted 3D-FLAIR, not 
shown) is multiplied by T2-weighed MR cisternography. Note that black areas (arrows) represent endolymphatic 
space in labyrinth and white areas represent perilymphatic space on HYDROPS-Mi2. Contrast between endo- and 
perilymphatic space is very strong, while the back ground signal is quite uniform on HYDROPS-Mi2. Lower row 
images indicate the generation of HYDROPS2-Mi2. HYDROPS2 image, which is the subtraction T2-weighed MR 
cisternography from positive perilymphatic image (heavily T2-weighted 3D-FLAIR, not shown) is multiplied by T2-
weighed MR cisternography. Note that black areas (arrows) represent endolymphatic space in labyrinth and white 
areas represent perilymphatic space on HYDROPS2-Mi2 similar to HYDROPS-Mi2. Contrast between endo- and 
perilymphatic space is very strong, while the back ground signal is quite uniform on HYDROPS2-Mi2 similar to 
HYDROPS-Mi2. With permission of Jpn J Radiol (58). 
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Fig. 5 A 42-years-old man with the clinical diagnosis of right sided definite Meniere’s disease. Images are 
obtained 24 hours after IT-GdC in the right ear and 4 hours after IV-SD-GBCM. The right ear shows IT+IV-GdC 
effect and the left ear shows only IV-GdC effect. Note that conventional 3D-FLAIR and 3D-real IR shows the 
sufficient enhancement of perilymph to recognize endolymphatic space only in the IT+IV side, however heavily T2-
weighted 3D-FLAIR and HYDROPS2 allows the differentiation between peri- and endolymphatic space on both IV 
side and IT+IV side. Significant endolymphatic hydrops (arrows) is seen in  cochlea and vestibule in the right side 
and no endolymphatic hydrpos is seen in the left cochlea. Absence of endolymphatic hydrops in the left vestibule is 
confirmed in lower level slices (not shown). With permission of Jpn J Radiol. (58) 
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The measurement of endolymph volume ratio following 3D-real inversion recovery images obtained 24 hours after 
intratympanic GdC using machine learning and automated local thresholding segmentation algorithms has been 
reported with highly reproducible results and a highly significant correlation between hearing loss and cochlear 
endolymphatic hydrops (93). Semi-automated volume ratio measurement of endolymph from images obtained 4 
hours after single dose intravenous GdC using short (8 minutes) and long (18 minutes) acquisition times (57) has 
been recommended. The correlation of the volume ratio between the long and short acquisition time images was 
high ranging from 0.77 (endolymphatic hydrops in the cochlea) to 0.99 (endolymphatic hydrops in the vestibule); 
the Pearsson’s correlation coefficients were all statistical significant (p<0.001). Later they demonstrated that 3-
Inversion-recovery turbo spin echo with real reconstruction (3D-real IR) showed higher contrast between the non-
enhanced endolymph and the surrounding bone (94) (fig. 6). Regular contrast 3D-FLAIR cannot readily visualize 
cochlear hydrops after single dose IV-Gd, especially in apical turn. Recently Naganawa et al. developed the 
positive endolymph image method, which visualizes endolymph as bright signal as well as subtraction images 
(HYDROPS images, HYbriD of Reversed image Of Positive endolymph signal and native image of positive 
perilymph Signal images) and allowed more easily interpretable images (85) (95). In our experience, using heavily 
T2-weighted 3D-FLAIR positive perilymph image (PPI)  and positive endolymph image (PEI) and subtracted 
images (HYDROPS technique) is useful to compensate for the lower concentration of Gd by IV.  A further 
developed technique for generating improved HYDROPS (i-HYDROPS) images allows for a higher contrast to 
noise ratio per unit time compared to conventional HYDROPS imaging; this is accomplished by elongating the 
repetition time and increasing the refocusing flip angle(96). In the study the size of the endolymphatic space was 
comparable in both the i-HYDROPS and 3D-real IR images.. The 3D-real IR does not require postprocessing for 
subtraction and might be more robust toward slight compositional alterations in endolymph than i-HYDROPS 
imaging-based on magnitude reconstruction and the scan time for 3D-real IR images was 10 min. 
 
Figure 4 (after IV. injection of GdC) and fig. 5 (after intratympanic injection of GdC) demonstrates the inner ear 
fluid compartments, anatomical structures and endolymphatic hydrops. Nakashima et al. (59), Pyykkö et al. (71) 
and Fiorino et al. (97) have demonstrated, with MRI, that endolymphatic hydrops was present in all living patients 
with definite MD, which is different from the reports by Shi et al. in which endolymphatic hydrops was absent in 
some definite MD (98). Recently it has been demonstrated that endolymphatic hydrops can affect the cochlear and 
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vestibular compartments differently and cause different complaints (71). However, the association between clinical 
symptoms and endolymphatic hydrops in individual patients is not yet clarified, as hearing can be relatively well 
preserved despite prominent endolymphatic hydrops (67) (99) and the extent of endolymphatic hydrops seems to 
vary along the course of the disease: it may increase, decrease or remain stable (100, 101) (102). With new imaging 
techniques, endolymphatic hydrops can be demonstrated in vivo and can confirm the diagnosis. Furthermore, it has 
become possible to evaluate MD using new functional tests, such as VEMP frequency tuning measurements, in 
patient populations with clinically and morphologically (by MRI detection of endolymphatic hydrops) confirmed 
diagnosis of MD (101) (103). 
 
Figure 6.. 3D Real reconstruction inversion recovery MRI of the right ear illustrates high signal-to-noise ratio and 
severe cochleovestibular endolmyphatic hydrops in a patient with Meniere’s disease 24 hours after intratympanic 
GdC application (Magnevist 1:8 diluted). Section thickness 0.3 mm. Siemens Verio scanner, 32-channel head coil. 
Endolymph appears black, perilymph appears white, temporal bone appears grey. The sections are positioned from 
left to right and from top to bottom so that they move through the inner ear in a caudal-to-cranial direction. The 
cochlea displays endolymphatic hydrops in all three turns. The vestibulum displays severe endolymphatic hydrops, 
with only a weak perilymph signal at its outer borders. The horizontal semicircular canal is completely visualized 
by its perilymph signal. (With kind permission of Prof. B. Ertl-Wagner, Institute of Clinical Radiology, University 
of Munich) 
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The current challenges in inner ear imaging are to improve the delivery of the contrast agent so that the 
concentration of GdC in the inner ear will exceed the detection limit.  The transtympanic and intravenous 
administrations have different indications (66). If the aim is to demonstrate an endolymphatic hydrops, then 
transtympanic injection of GdC is preferred. Usually the transtympanic administration provides stronger uptake and 
is easier to assess than intravenous injection. In principle, the sensitivity of the intravenous and the transtympanic 
method to demonstrate endolymphatic hydrops in the inner ear should be similar based on sufficient uptake of GdC 
in the inner ear, as both methods measure the same phenomenon (87). A technique in which the images of inverted 
grey-scale positive endolymph are subtracted from images with native positive perilymph images is useful when 
inner ear loading of GdC is low. This subtraction significantly improves the contrast noise ratio and assists in 
separation of endolymph, perilymph  and bone (104) or when combining intravenous injection with transtympanic 
injection (68). 
 
The development of dynamic imaging techniques of the inner ear has provided several important new insights into 
MD; 1) the cochlear and vestibular compartments can be differently affected, and 2) in about 24 -75% of the cases 
the disease is bilateral (71)  (105).  3) The extent of endymphatic hydrops can vary during time in individual 
patients (102). 4) the extent of the endolymphatic hydrops does not correlate with complaints (86). The variable 
latency between complaints in MD (71)  and bilateral nature of the disease confirms (106) (107)  the observations 
in MRI   (71) Unilateral disease was reported to progress to bilateral disease in up to 35% of patients within 10 
years and in up to 47% within 20 years of follow up (108, 109). The vestibule showed endolymphatic hydrops 
more frequently than did the cochlea although most commonly the endolymphatic hydrops was found in both 
cochlea and vestibule (71). Patients with sudden deafness and in spontaneous tinnitus often had endolymphatic 
hydrops (71). Whether endolymphatic hydrops will develop in all forms of tinnitus is not known but is worth 
studying. The application of endolymphatic hydrops imaging in patients with various inner ear symptoms and 
disorders has shown that endolymphatic hydrops is not only present in cases of typical MD, but also in its 
monosymptomatic variants and in the conditions of secondary endolymphatic hydrops. These observations have 
coined the term “Hydropic Ear Disease”, allowing for a logic and comprehensive classification of these disorders 
(110). 
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Furthermore, clinical imaging of endolymphatic hydrops has shown that 1) endolymphatic hydrops progresses with 
time, both on the cross-sectional level (72) and on the individual level (101),  2) the severity of cochlear and 
vestibular function deficits are generally correlated with the severity of endolymphatic hydrops (72),  3) the 
hydropic herniation of vestibular endolymphatic spaces into the semicircular canal can be visualized in-vivo (111) 
and - with the advent of accurate measurements of the vestibule-ocular reflex (VOR) at high frequencies (Video 
Head Impulse Test)  offers a possible explanation for the well-known paradox of horizontal semicircular canal 
dysfunction in MD: while the (low-frequency) caloric response is impaired, the (high frequency) head impulse test 
is typically normal (112)(113) (114).  
 
Legend for table 2. Inner ear pathology with MRI with different application routes of contrast agent used for 
visualizing different nature of the disorder. 
Disease Membranous labyrinth injury Delivery route of Gd 
Ménière’s disease Reissner’s membrane bulging, 
rarely a  rupture 
Transtympanic delivery 
/Intravenous delivery 
Inner ear immune disorder Stria vascularis pathology/ 
Endolymphatic hydrops 
Intravenous delivery or 
Intratympanic delivery 
Circulatory disturbances Stria vascularis pathology Intravenous delivery 
Spontaneous membrane rupture Reissner’s membrane  Intravenous delivery or 
Intratympanic delivery 
Perilymphatic fistula Round window membrane rupture 
or semicircular canal injury 
Intravenous delivery or 
Intaratympanic delivery 
Trauma (mechanical and noise) Stria vascularis pathology Intravenous delivery 
 
 
In clinical practice, the question is often pending, which GdC delivery pathway should be taken; the intratympanic 
or the intravenous delivery? Table 2 demonstrates the alternative strategies to visualize inner ear disorders in 
different disease and suspected pathologies. The benefit of intratympanic delivery is that most often the GdC 
concentration is greater in transtympanic delivery than in intravenous delivery and the pathology is easier to assess 
20 
 
(Figure 5). However, even with this delivery route in our hands, occasionally the inner ear shows insufficient 
concentration of GdC in the perilymph and assessment of the disorder may be difficult.  
Future development 
1. Novel contrast agents: 
Novel highly sensitive, specific, and low-toxicity contrast agents for MRI and MDCT are in urgent need in 
the clinic. For MRI manganese-containing contrast agents would be most suitable as these can demonstrate the 
calcium metabolism that is inherent in disease processes in the inner ear (115) (116) (117) (118). Nanoparticle 
based GdC carrier  can be  are an effective MRI T1 contrast agent and have been used in high resolution MRI for 
tracing apoptosis and gene transcription in animal models of cerebral ischemia and brain tumours(119)(120). A 
novel type of super-paramagnetic iron oxide nanoparticles (SPIONs) that is water soluble, a characteristic that can 
be invaluable for medical applications has been designed (Fig. 7) (121, 122 ). It is constructed from iron oxide 
nanoparticle cores with a hierarchical coating consisting of a surface layer of Pluornic® F127 copolymer (PF127, 
approved by the Food and Drug Administration) that overlays a layer of oleic acid on the surface of the iron oxide 
nanoparticles (POA@SPIONs). POA@SPIONs is a promising T2 negative contrast agent that is detectable within 
the inner ear by MR imaging (123). Functionalization of POA@SPIONs can be performed and will make it 
targetable to inflammatory cytokines in the inner ear; however, the POA@SPIONs did not enter the inner ear 
efficiently after the transtympanic injection (106). Another novel highly hydrophilic anti-aggregative super-
paramagnetic maghemite (γ-Fe2O3) nanoparticles (NPs) was developed using ceric ammonium nitrate (CAN)-
mediated oxidation of starting magnetite (Fe3O4) NPs (CAN-γ-Fe2O3 NPs), which were highly stable aqueous 
suspensions/ferrofluids due to a unique ultrasound-mediated doping process of the Fe3O4 NP surface using 
lanthanide Ce3/4+ cations (124). Zou et al. have also demonstrated that the novel CAN-γ-Fe2O3 NPs is a strong T2 
MRI contrast agent and penetrates both round and oval windows, which has potential applications in molecular 
imaging of the inner ear (125). 
Figure 7. Super-paramagnetic iron oxide nanoparticles (SPION) contrasted inner ear in rat. The SPION 
administered into the perilymph will extinguish the signal from the perilymph and only endolymphatic spaces are 
visible on MRI. Reprinted with permission of Europ J nanomed (122). Cochlea, vestibule and the semicircular 
canals are shown.   
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By developing a novel nanomaterial to be used as contrasting agent for example encapsulation of metals and metal 
clusters in fullerenes (endohedral metallofullerenes) opens additional vistas for inner ear imaging (126) (127) 
(128). The carbon cage has inherent advantages because of its high stability and characteristic resistance to any 
potential metabolic cage-opening process. This prevents the release of toxic metal ions from endohedral 
metallofullerenes into surrounding tissue, serum, and other biologic components (126). Water-soluble endohedral 
gadolinium-lutetium fullerene is generating considerable interest because of the possibility of using these novel 
nanomaterials as both MRI and MDCT imaging contrast agents. It is possible in the future medicine that specific 
molecular MRI and MDCT imaging can be performed after single injection of the targetable dual contrast agent.  
 
2. Targeted contrast agents:  
Contrast agents to enhance or darken fluid or tissue signals help to visualize regions of interest and efforts 
are now being made to create biological tags using these agents for molecular imaging at the level of cellular 
processes. Aimed to visualize liposome nanoparticles in the inner ear, GdC-encapsulated liposomes were 
developed and distribution of the nanoparticles in the cochlea was detected in vivo using MRI after either 
intracochlear injection or intratympanic injection (129-131).  These studies open a window in specific visualization 
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of inner ear pathology using MRI. GdC-encapsulated liposomes pass through both the oval and round windows and 
was not toxic in in-vivo experiments. Potential molecular imaging in the inner ear using the novel CAN-γ-Fe2O3 
NPs was also demonstrated in an animal study (132)The novel NPs are especially useful for molecular imaging of 
the inner ear to detect molecular changes in pathological conditions. 
3. Microtomgraphy (μCT) 
In CT the cochlear partition and soft tissue as membranes are not adequately visualized (10) (11). The gray levels 
in a CT slice image correspond to X-ray attenuation, which reflects the proportion of X-rays scattered or absorbed 
as they pass through each voxel, and is affected by the density and composition of the material being imaged. Non-
destructive X-ray microtomography (μCT) has proven its utility in 3D assessment of mineralized and soft tissue 
morphology (133) (134). The cochlear partition and the basilar membrane could not be distinguished and 
reconstructed with µCT (134) Recently Poznyakovskiy et al. presented an algorithm for cochlear segmentation, 
which resulted in the reconstruction of scala tympani (135). µCT has been engaged in middle and inner ear imaging 
of animals and implicated to be a useful tool to trace distribution of drugs in the inner ear. However, it can only be 
used for ex-vivo imaging due to the extremely high dose of exposure and the close imaging distance which is only 
suitable for the head (136). The contrast enhanced μCT methodology is further developed for ex-vivo cochlear 
imaging (28). It can demonstrate the position of Reissner’s membrane and basilar membrane if a contrast agent is 
used (136). Figure 8 demonstrates CI imaged with μCT. However, μCT produces extremely high radiation dose and 
in present form cannot be applied in humans.  
 
Recently this technique has been advanced in animal experiments by revealing the inner ear compartment with 
simultaneous 9T MRI scanner and μCT (2). The combined MRI-µCT imaging techniques were complementary, 
and provided high-resolution dynamic and static visualization of the morphological features of the normal mouse 
inner ear structures. 
Figure 8. Imaging of CI electrode with µCT, Left figure shows the base electrodes stimulating areas close to the 
round window, The right figure shows the first and second tip electerodes aimed to stinmulate apex of the cochlea. 
The bars indicate distance of 100 µm, 
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4. High-resolution coherent anti-Stokes Raman spectroscopy (CARS)  
Raman spectroscopy is a powerful tool to generate a characteristic signature of specific tissues and operates by 
detecting energy with the molecular bond vibration of incident photons. The process results in non-elastically 
scattered light, also known as Raman scattering(137) Raman spectroscopy is capable of discerning molecular 
pathology of differential proliferative middle ear lesions and may provide an aid in assessment of the borders of the 
pathological process in order to improve surgical outcome of the middle ear diseases (138)(139)(140)(141)(7). 
CARS occurs when a target molecule is irradiated using two laser beams simultaneously at different frequencies, a 
pump beam and a Stokes beam. When the difference between the higher frequency (pump beam) and the lower 
frequency (Stokes beam) equals the vibrational frequency of the target bond of the molecule, a CARS signal is 
generated (139) (140) (141).  Zou et al (7) has recently demonstrated the feasibility of using CARS microscopy to 
display the specific molecular morphology of cholesteatoma that has the potential to be integrated in a novel 
endoscope for cholesteatoma imaging in the clinic. There are reports on developing CARS endoscopes, although 
the system needs further improvement (142, 143).  
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Conclusions. 
Temporal bone imaging should be sensitive enough to reveal functional disorders after trauma, inflammatory 
diseases, space occupying lesions such as cholesteatoma or vestibular schwannoma, changes in bone density such 
as otoscleosis, disruption of ossicular chain, various congenital anomalies, vascular malformations and position and 
insertion depth of cochlear implants. MDCT and CBCT have the benefit that they accurately describe the bony 
structures of the temporal bone. During CBCT imaging, the dose is applied to a very narrow section of the body 
with minimum exposure of the non-targeting area to radiation, and the total X-ray dose is lower compared with 
MDCT. In addition, CBCT’s rapid data acquisition means that only a low dose of radiation is created during the 
imaging. MRI, especially at a field strength of 3T, is excellent in revealing changes of the soft tissues and fluid 
spaces in the temporal bone. The 3T MRI allows relatively accurate visualization of endolymphatic hydrops and 
even the membranous structures of the inner ear.  Modern trends with targeted imaging of the inner ear may 
provide possibilities to visualize inner ear pathologies that can be assessed today only on histology. The recent 
imaging possibilities to explore inner ear fluid spaces are especially encouraging and contribute to clinical practice 
by defining Hydropic Ear Disease as a new entity.  
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